Detalhe da pesquisa
1.
PML/RARA inhibits expression of HSP90 and its target AKT.
Br J Haematol
; 184(6): 937-948, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30536958
2.
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy.
Acta Oncol
; 58(6): 888-890, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30848978
3.
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.
Leukemia
; 37(8): 1600-1610, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37349598
4.
Identification of a potential topoisomerase II "hotspot" DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms.
Ann Hematol
; 96(1): 155-157, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27734129
5.
Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia.
Acta Oncol
; 56(8): 1120-1121, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28406054
6.
Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation.
Acta Oncol
; 56(10): 1331-1333, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28488914
7.
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.
Cancers (Basel)
; 14(10)2022 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35626170
8.
NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.
Mediterr J Hematol Infect Dis
; 12(1): e2020083, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33194157
9.
PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells.
Cancers (Basel)
; 12(1)2019 Dec 30.
Artigo
Inglês
| MEDLINE | ID: mdl-31905996
10.
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes.
Support Care Cancer
; 21(7): 1803-5, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23604522
11.
PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) induce apoptosis in K562 cells.
BMC Cancer
; 7: 207, 2007 Nov 09.
Artigo
Inglês
| MEDLINE | ID: mdl-17996085
12.
High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.
Oncotarget
; 8(20): 32550-32565, 2017 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-28427227
13.
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant.
J Med Chem
; 49(19): 5840-4, 2006 Sep 21.
Artigo
Inglês
| MEDLINE | ID: mdl-16970408
14.
A case of SRSF2 mutation in chronic lymphocytic leukemia.
Leuk Res Rep
; 6: 11-4, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27453816
15.
PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity.
Oncotarget
; 7(41): 66386-66397, 2016 Oct 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27626703
16.
Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes.
J Mol Diagn
; 17(1): 85-9, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25445211
17.
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation.
Hematol J
; 5(1): 24-31, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-14745426
18.
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors.
Transfus Apher Sci
; 26(2): 103-10, 2002 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-12121064
19.
The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature
Cardiovasc Hematol Agents Med Chem
; 11(1): 67-76, 2013 03.
Artigo
Inglês
| MEDLINE | ID: mdl-23016546
20.
The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes.
Cardiovasc Hematol Agents Med Chem
; 10(4): 362-75, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-22721442